CEL-SCI Corporation CVM
At closeNov 10, 2026, 4:00 PM EST
After hours · Nov 10, 4:00 PM ET
- YTD
- -73.19%
- 1 year
- -80.39%
Discussion (164)
Sign in to join the discussion
I am a retired H&N surgeon. I have followed and owned this stock since I first saw reports of the effectiveness of lymphokine in the early 90s. There are ZERO truly effective chemotherapeutic agents for th I type of tumor lymphokine treats. The study showed there was definite benefit to 5 year survival with -importantly - NO SIDE EFFECTS. With this in mind even if potential effect is limited, there is no reason not to approve lymphokine. The only thing potentially standing in the way is the poisoning of the FDA by big pharma. Lymphokine is an orphan drug and should have been fast tracked. Worrisome.
Legal problems with the SEC? That fucking Dept doesn’t even go after obvious fail to deliver. How pathetic is that?
Wayne I just need a whiff of 6
I’d bring up #4’s rear Wayne
Little does Wall Street know what’s about to play out and neither do you people. Watch for a huge surprise and quote me.
Russia best KGB agent disguised as a female?
Here ya go Wayne
Wayne gaze into the looking glass it’s close
Aye Captain there she blows and she’s a big one.
